Cargando…
Clinical trials waiver in India-some considerations
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044129/ https://www.ncbi.nlm.nih.gov/pubmed/30100660 http://dx.doi.org/10.4103/ijp.IJP_540_17 |
| _version_ | 1783339421364387840 |
|---|---|
| author | Juneja, Atul Adhikari, Tulsi |
| author_facet | Juneja, Atul Adhikari, Tulsi |
| author_sort | Juneja, Atul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6044129 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60441292018-08-10 Clinical trials waiver in India-some considerations Juneja, Atul Adhikari, Tulsi Indian J Pharmacol Letter to the Editor Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6044129/ /pubmed/30100660 http://dx.doi.org/10.4103/ijp.IJP_540_17 Text en Copyright: © 2018 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Juneja, Atul Adhikari, Tulsi Clinical trials waiver in India-some considerations |
| title | Clinical trials waiver in India-some considerations |
| title_full | Clinical trials waiver in India-some considerations |
| title_fullStr | Clinical trials waiver in India-some considerations |
| title_full_unstemmed | Clinical trials waiver in India-some considerations |
| title_short | Clinical trials waiver in India-some considerations |
| title_sort | clinical trials waiver in india-some considerations |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044129/ https://www.ncbi.nlm.nih.gov/pubmed/30100660 http://dx.doi.org/10.4103/ijp.IJP_540_17 |
| work_keys_str_mv | AT junejaatul clinicaltrialswaiverinindiasomeconsiderations AT adhikaritulsi clinicaltrialswaiverinindiasomeconsiderations |